• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症代谢与转移的动态过程。

Cancer metabolism and the dynamics of metastasis.

作者信息

Dattoli G, Guiot C, Delsanto P P, Ottaviani P L, Pagnutti S, Deisboeck T S

机构信息

ENEA, Dip. FIM, Unità di Fisica Teorica & Matematica Applicata, Centro Ricerche Frascati, 00044 Frascati, Rome, Italy.

出版信息

J Theor Biol. 2009 Feb 7;256(3):305-10. doi: 10.1016/j.jtbi.2008.10.008. Epub 2008 Oct 21.

DOI:10.1016/j.jtbi.2008.10.008
PMID:18996401
Abstract

Cancer growth dynamics, commonly simulated with a Gompertzian model, is analyzed in the framework of a more recent and realistic model. In particular, we consider the setting of a tumor embedded in a host organ and investigate their interaction. We assume that, at least in some cases, tumor metastasis may be triggered by an 'energetic crisis', when the tumor exceeds the 'carrying capacity' of the host organ. As a consequence, dissemination of clusters of cancer cells is set in motion, with a statistical probability given by a Poisson distribution. The model, although still at a preclinical level, is fully quantitative and is applied, as an example, to the case of prostate cancer. The results confirm that, at least for the more aggressive cancers, metastasis starts very early during tumorigenesis and a quantitative link is found between the tumor's doubling time, its 'aggressiveness' and the metastatic potential.

摘要

通常用冈珀茨模型模拟的癌症生长动力学,在一个更新的、更现实的模型框架下进行了分析。具体而言,我们考虑肿瘤嵌入宿主器官的情况,并研究它们之间的相互作用。我们假设,至少在某些情况下,当肿瘤超过宿主器官的“承载能力”时,肿瘤转移可能由“能量危机”引发。结果,癌细胞团簇的扩散开始启动,其统计概率由泊松分布给出。该模型虽然仍处于临床前水平,但完全是定量的,并作为示例应用于前列腺癌病例。结果证实,至少对于侵袭性更强的癌症,转移在肿瘤发生的早期就开始了,并且在肿瘤的倍增时间、其“侵袭性”和转移潜能之间发现了定量联系。

相似文献

1
Cancer metabolism and the dynamics of metastasis.癌症代谢与转移的动态过程。
J Theor Biol. 2009 Feb 7;256(3):305-10. doi: 10.1016/j.jtbi.2008.10.008. Epub 2008 Oct 21.
2
Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection.实体癌转移时大小的非参数估计及检测时出现转移的概率。
Biometrics. 1997 Jun;53(2):579-91.
3
Estimating a distribution function of the tumor size at metastasis.估计转移时肿瘤大小的分布函数。
Biometrics. 1998 Sep;54(3):859-64.
4
A novel model of bone-metastatic prostate cancer in immunocompetent mice.一种在免疫健全小鼠中建立骨转移性前列腺癌的新模型。
Prostate. 2009 Nov 1;69(15):1613-23. doi: 10.1002/pros.21010.
5
Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform.FTY720抑制雄激素非依赖性前列腺癌细胞的侵袭性:验证Runx2作为潜在的抗转移药物筛选平台
Clin Cancer Res. 2009 Jul 1;15(13):4322-35. doi: 10.1158/1078-0432.CCR-08-3157. Epub 2009 Jun 9.
6
Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.小干扰RNA定向靶向Toll样受体4可抑制人前列腺癌细胞的侵袭、存活及致瘤性。
Mol Immunol. 2009 Sep;46(15):2876-84. doi: 10.1016/j.molimm.2009.06.016. Epub 2009 Jul 29.
7
Prostate specific antigen half-time and prostate specific antigen doubling time as predictors of response to androgen deprivation therapy for metastatic prostate cancer.前列腺特异性抗原半衰期和前列腺特异性抗原倍增时间作为转移性前列腺癌雄激素剥夺治疗反应的预测指标。
J Urol. 2009 Jun;181(6):2520-4; discussion 2525. doi: 10.1016/j.juro.2009.01.104. Epub 2009 Apr 16.
8
[Expression of Smad4 in prostate cancer LNCaP and ARCaP cell lines with different metastatic potentials and its significance].[不同转移潜能前列腺癌细胞系LNCaP和ARCaP中Smad4的表达及其意义]
Zhonghua Nan Ke Xue. 2009 Jan;15(1):41-4.
9
A minimal model of tumor growth inhibition.肿瘤生长抑制的最小模型。
IEEE Trans Biomed Eng. 2008 Dec;55(12):2683-90. doi: 10.1109/TBME.2008.913420.
10
Physical aspects of cancer invasion.
Phys Biol. 2007 Dec 17;4(4):P1-6. doi: 10.1088/1478-3975/4/4/P01.

引用本文的文献

1
Multiscale systems pharmacological analysis of everolimus action in hepatocellular carcinoma.多尺度系统药理学分析依维莫司在肝细胞癌中的作用。
J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):607-620. doi: 10.1007/s10928-018-9590-0. Epub 2018 May 3.
2
Simulating cancer growth with multiscale agent-based modeling.使用基于多尺度智能体的建模方法模拟癌症生长。
Semin Cancer Biol. 2015 Feb;30:70-8. doi: 10.1016/j.semcancer.2014.04.001. Epub 2014 May 2.
3
Modeling the connection between primary and metastatic tumors.模拟原发性肿瘤与转移性肿瘤之间的联系。
J Math Biol. 2013 Sep;67(3):657-92. doi: 10.1007/s00285-012-0565-2. Epub 2012 Jul 25.
4
Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer.利用肿瘤动力学来阐明前列腺癌生化复发列线图中观察到的可变性。
Prostate. 2012 Feb;72(3):280-90. doi: 10.1002/pros.21429. Epub 2011 May 31.
5
A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.25 年血浆脂联素和瘦素浓度与前列腺癌风险和生存的前瞻性研究。
Clin Chem. 2010 Jan;56(1):34-43. doi: 10.1373/clinchem.2009.133272. Epub 2009 Nov 12.